Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001062993-22-012945 | Dec 31st, 2021 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | CIM INVESTMENT MANAGEMENT INC | 1179791 | AbbVie Inc | COM | 00287Y109 | 690 | 5099 | SH | SOLE | 5099 | 0 | 0 | May 20th, 2022 01:06AM | May 20th, 2022 01:06AM | Health Care | Pharmaceuticals & Biotechnology | ||
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001065350-22-000005 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital Group Private Client Services, Inc. | 1857666 | ABBVIE INC | COM | 00287Y109 | 20714 | 127778 | SH | SOLE | 127146 | 0 | 632 | May 20th, 2022 01:06AM | May 20th, 2022 01:06AM | Health Care | Pharmaceuticals & Biotechnology | ||
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001065350-22-000006 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital International Investors | 1562230 | ABBVIE INC | COM | 00287Y109 | 4943993 | 30497767 | SH | DFND | 1, 2 | 30497340 | 0 | 427 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | |
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001065350-22-000007 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital Group International, Inc./CA/ | 895213 | ABBVIE INC | COM | 00287Y109 | 4377 | 26998 | SH | DFND | 1, 2 | 26998 | 0 | 0 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | |
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001065350-22-000009 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital International Sarl | 1065349 | ABBVIE INC | COM | 00287Y109 | 2934 | 18100 | SH | DFND | 1, 2 | 18100 | 0 | 0 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | |
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001065350-22-000010 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Capital Research Global Investors | 1422848 | ABBVIE INC | COM | 00287Y109 | 2768875 | 17080211 | SH | DFND | 1, 2 | 17079481 | 0 | 730 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | |
nyse:abbv | nyse:abbv Shareholders | 13F-HR | 0001580642-22-002805 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Orion Portfolio Solutions, LLC | 1802647 | ABBVIE INC | COM | 00287Y109 | 3581 | 22091 | SH | SOLE | 0 | 0 | 22091 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | ||
nyse:abbv | nyse:abbv Shareholders | 13F-HR | 0001606587-22-001224 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | WESPAC Advisors SoCal, LLC | 1668188 | ABBVIE INC | COM | 00287Y109 | 5693 | 35117 | SH | SOLE | None | 0 | 0 | 35117 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | |
nyse:abbv | nyse:abbv Shareholders | 13F-HR | 0001720777-22-000002 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Strategic Wealth Partners, Ltd. | 1720777 | ABBVIE INC | COM | 00287Y109 | 2713 | 16734 | SH | SOLE | 0 | 0 | 0 | 16734 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology | |
nyse:abbv | nyse:abbv Shareholders | 13F-HR/A | 0001776033-22-000003 | Mar 31st, 2022 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | Golden State Wealth Management, LLC | 1776033 | ABBVIE INC | Common Stock | 00287Y109 | 568 | 3504 | SH | SOLE | 1483 | 0 | 2020 | May 20th, 2022 01:07AM | May 20th, 2022 01:07AM | Health Care | Pharmaceuticals & Biotechnology |